Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07350486 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia

Study acronym: LLM-CoManage
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Not Yet Recruiting → Active, Not Recruitingv3 Show 4 more changesShow less
    • Trial sites expanded: 1 → 6 locations
    • Primary completion moved earlier from Jun 30, 2027 to Mar 31, 2027
    • Study completion moved earlier from Dec 31, 2027 to Apr 30, 2027
    • Start date changed from estimate of Jun 15, 2026 to May 14, 2026
  2. Enrollment increased: 6000 → 6800 participants
    • Interventions: LLM-Enabled Clinician-Patient Co-management (Other) to LLM-Enabled Co-management (Other)
    • Secondary endpoints revised (17)
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the effectiveness of a large language model (LLM)-supported, community-based integrated management model in improving cardiometabolic multimorbidity control among adults with hypertension and coexisting diabetes or dyslipidemia. Adopting an interventional study design, eligible patients will be recruited to compare the disease control indicators between LLM-assisted management and conventional management, so as to verify the effectiveness and safety of the former.
Trial Details
NCT Number NCT07350486
Lead Sponsor First Hospital of China Medical University
Collaborators: Beijing Chao Yang Hospital, Zhejiang University, Shandong Provincial Hospital, Cangzhou Central Hospital
Conditions
(from sponsor)		 Hypertension, Diabetes, Dyslipidemia
Related terms Diabetes Mellitus, Dyslipidemias, Hypertension
Enrollment 6,800 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov